NYSE:OMI - Owens & Minor Stock Price, News, & Analysis

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Owens & Minor declared a quarterly dividend on Monday, May 13th. Investors of record on Friday, June 14th will be given a dividend of $0.0025 per share on Friday, June 28th. This represents a $0.01 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date is Thursday, June 13th. View Owens & Minor's Dividend History.

Owens & Minor, Inc. (NYSE:OMI) announced its quarterly earnings data on Tuesday, May, 7th. The company reported $0.02 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.02. The business earned $2.46 billion during the quarter, compared to analyst estimates of $2.45 billion. Owens & Minor had a positive return on equity of 6.92% and a negative net margin of 4.63%. The firm's quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.43 earnings per share. View Owens & Minor's Earnings History.

Owens & Minor is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Owens & Minor.

Owens & Minor updated its FY19 earnings guidance on Tuesday, May, 7th. The company provided earnings per share (EPS) guidance of $0.60-0.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.66. Owens & Minor also updated its FY 2019 guidance to $0.60-0.75 EPS.

5 Wall Street analysts have issued 12-month target prices for Owens & Minor's shares. Their forecasts range from $4.50 to $9.00. On average, they anticipate Owens & Minor's share price to reach $6.70 in the next twelve months. This suggests a possible upside of 138.4% from the stock's current price. View Analyst Price Targets for Owens & Minor.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Owens & Minor.

News headlines about OMI stock have trended somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Owens & Minor earned a news impact score of 1.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Owens & Minor.

Some companies that are related to Owens & Minor include Vericel (VCEL), Estia Health (EHE), Hanger (HNGR), Advanced Medical Solutions Group (AMS), G1 Therapeutics (GTHX), Twist Bioscience (TWST), Intra-Cellular Therapies (ITCI), Clovis Oncology (CLVS), Adverum Biotechnologies (ADVM), MeiraGTx (MGTX), CannTrust (CTST), Avita Medical (AVH), Organogenesis (ORGO), Arvinas (ARVN) and Odonate Therapeutics (ODT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include AT&T (T), Micron Technology (MU), AbbVie (ABBV), Cisco Systems (CSCO), Alibaba Group (BABA), Omega Healthcare Investors (OHI), Applied Materials (AMAT), 3M (MMM), Tanger Factory Outlet Centers (SKT) and Simon Property Group (SPG).

Owens & Minor's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.60%), Dimensional Fund Advisors LP (7.85%), JPMorgan Chase & Co. (4.64%), LSV Asset Management (2.99%), Parametric Portfolio Associates LLC (2.81%) and Morgan Stanley (2.35%). Company insiders that own Owens & Minor stock include Charles C Colpo and Geoff Taylor Marlatt. View Institutional Ownership Trends for Owens & Minor.

OMI stock was sold by a variety of institutional investors in the last quarter, including Brandes Investment Partners LP, Advisors Asset Management Inc., Charles Schwab Investment Management Inc., LSV Asset Management, North Star Investment Management Corp., Wells Fargo & Company MN, Rhumbline Advisers and Pinebridge Investments L.P.. Company insiders that have sold Owens & Minor company stock in the last year include Charles C Colpo and Geoff Taylor Marlatt. View Insider Buying and Selling for Owens & Minor.

OMI stock was bought by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, OppenheimerFunds Inc., Parametric Portfolio Associates LLC, Renaissance Technologies LLC, Royce & Associates LP, Morgan Stanley, Acadian Asset Management LLC and Trexquant Investment LP. View Insider Buying and Selling for Owens & Minor.

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of OMI stock can currently be purchased for approximately $2.81.

Owens & Minor has a market capitalization of $176.86 million and generates $9.84 billion in revenue each year. The company earns $-437,010,000.00 in net income (profit) each year or $1.15 on an earnings per share basis. Owens & Minor employs 17,900 workers across the globe.View Additional Information About Owens & Minor.

The official website for Owens & Minor is http://www.owens-minor.com/.

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]